Metropolitan Life Insurance Company (MetLife)’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-8,878
Closed -$252K 2376
2021
Q4
$252K Buy
8,878
+24
+0.3% +$746 ﹤0.01% 1858
2021
Q3
$282K Sell
8,854
-354
-4% -$11.9K ﹤0.01% 1823
2021
Q2
$319K Buy
9,208
+3
+0% +$99 ﹤0.01% 1808
2021
Q1
$271K Buy
9,205
+356
+4% +$10.9K ﹤0.01% 1804
2020
Q4
$271K Buy
8,849
+822
+10% +$25.1K ﹤0.01% 1735
2020
Q3
$224K Sell
8,027
-115
-1% -$2.91K ﹤0.01% 1706
2020
Q2
$175K Sell
8,142
-1,476
-15% -$32.6K ﹤0.01% 1894
2020
Q1
$215K Buy
9,618
+552
+6% +$15.1K ﹤0.01% 1547
2019
Q4
$267K Buy
9,066
+30
+0.3% +$815 ﹤0.01% 1716
2019
Q3
$240K Sell
9,036
-6,755
-43% -$203K ﹤0.01% 1754
2019
Q2
$534K Sell
15,791
-266
-2% -$8.64K 0.01% 1259
2019
Q1
$515K Buy
16,057
+12,494
+351% +$384K 0.01% 1277
2018
Q4
$112K Buy
+3,563
New +$117K ﹤0.01% 2196

Other funds holding ELAN

Metropolitan Life Insurance Company (MetLife)'s ELAN Position: Q1 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Elanco Animal Health (ELAN) in Q1 2022, closing a stake of 8,878 shares — an estimated $252K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ELAN in Q4 2018 and held it in 13 quarters. The position peaked at $534K in Q2 2019. 472 funds tracked by Wall St. Rank hold ELAN as of Q1 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Elanco Animal Health position as of Q1 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 8,878 Elanco Animal Health shares in Q1 2022, an estimated $252K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Elanco Animal Health in Q4 2018 and held it in 13 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Elanco Animal Health position peaked at $534K in Q2 2019.
  • 472 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.